These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20446556)

  • 1. Drug-induced diseases focus of pharmacy manual.
    Sipkoff M
    Manag Care; 2010 Apr; 19(4):11-2. PubMed ID: 20446556
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of advanced pharmaceutical services on the incidence of adverse drug reactions.
    McKenney JM; Wasserman AJ
    Am J Hosp Pharm; 1979 Dec; 36(12):1691-7. PubMed ID: 525645
    [No Abstract]   [Full Text] [Related]  

  • 3. Complying with the most challenging 1998 long term care pharmacy standards.
    Jt Comm Perspect; 1998; 18(5):11-4. PubMed ID: 10187290
    [No Abstract]   [Full Text] [Related]  

  • 4. Procedure manual for drug monitoring in the Canadian hospital, approved by CSHP Council May 1978.
    Can J Hosp Pharm; 1979; 32(3):82-5, 87. PubMed ID: 10242860
    [No Abstract]   [Full Text] [Related]  

  • 5. [New working environment program. A manual on chemical substances].
    Lernevall I
    Vardfacket; 1985 Mar; 9(5):18. PubMed ID: 3849221
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of two self-instructional manuals on adverse drug reaction monitoring.
    Ruck BE; Hatton RC; Doering PL
    Am J Hosp Pharm; 1990 Sep; 47(9):2062-4. PubMed ID: 2244946
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacist on your health team. A meaningful pharmacy policy and procedures manual.
    Machbitz JM
    Nurs Homes; 1972 Oct; 21(10):12 passim. PubMed ID: 4485631
    [No Abstract]   [Full Text] [Related]  

  • 8. Patient care manual describes duties of pharmacy consultant and nursing service personnel.
    Mod Nurs Home; 1970 Jul; 25(1):10-1. PubMed ID: 5200669
    [No Abstract]   [Full Text] [Related]  

  • 9. [The new pharmaceutical manual and citizens' rights. The viewpoint of the Italian Society of Hospital Pharmacy].
    Martini N
    Recenti Prog Med; 1994 May; 85(5):267-8. PubMed ID: 8023003
    [No Abstract]   [Full Text] [Related]  

  • 10. Policy and procedure manual. Use of medications for indications, dosages and/or routes of administration not listed in the FDA literature.
    Curr Concepts Hosp Pharm Manage; 1988; 10(1):20. PubMed ID: 10317998
    [No Abstract]   [Full Text] [Related]  

  • 11. Recent revisions to the State Operations Manual: implications for the management of urinary incontinence.
    Oliff L
    Director; 2007; 15(2):12-6. PubMed ID: 19343902
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug-induced shock].
    Rudzki E; Stodolnik E; Chruściel TL
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1621-3. PubMed ID: 6679087
    [No Abstract]   [Full Text] [Related]  

  • 13. A new approach to delivering drug information to the physician through a pharmacy consultation program. IV. Evaluation results.
    Bell JE; Bouchard VE; South JC; Duffy GM
    Am J Hosp Pharm; 1973 Apr; 30(4):300-10. PubMed ID: 4697653
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):117-32. PubMed ID: 14998074
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2002 Sep; 11(6):529-44. PubMed ID: 12426939
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacoepidemiology and drug safety.
    Pharmacoepidemiol Drug Saf; 2001; 10(5):467-82. PubMed ID: 11802594
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adverse effects of drugs: mechanisms and factors affecting their occurrence].
    Mèszàros J
    Pol Tyg Lek; 1983 Dec 19-26; 38(51-52):1615-20. PubMed ID: 6679086
    [No Abstract]   [Full Text] [Related]  

  • 18. Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 2.
    Manasse HR
    Am J Hosp Pharm; 1989 Jun; 46(6):1141-52. PubMed ID: 2750765
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug interactions in the practice. Which combinations are taboo?].
    Zolk O; el-Armouche A; Eschenhagen T
    MMW Fortschr Med; 2001 Dec; 143(51-52):24-32. PubMed ID: 11824161
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse drug reactions.
    White LM; Gardner SF; Talley JD
    J Ark Med Soc; 1996 Dec; 93(7):340-2. PubMed ID: 8990765
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.